Home
Archived Segments
Written Scripts
   

Emmy award-winning reporter John Biffar, hosts the local medical series Health Matters which airs on NBC2 News Today weekday mornings between 5-5:30 a.m. and during NBC2 News at 4:00 p.m.
 
 
 

      

Mammosite
November 17, 2008

Dr. Thomas Carrasquillo has experienced success with a new radiation treatment for breast cancer patients. The treatment is called Mammosite.

“Mammosite is what we call partial breast radiation and that is we only give radiation in the area where the original tumor existed,” he says.

Most patients, who have a tumor removed from their breast, need to undergo radiation to help prevent the cancer from returning. “The reason we give radiation after the tumor is removed is because we do worry that there may be some cells which have come loose from the original tumor. The most recent type of radiation treatment that was being used was giving the entire breast radiation and that usually involved daily treatments in the vicinity of six to seven weeks,” says Dr. Carrasquillo.

Because Mammosite localizes radiation, the treatment process is faster. “One of the big benefits is that the treatments are done twice a day, only for five days so it’s a much shorter treatment.” Dr. Carrasquillo adds that not every breast cancer patient will meet the criteria for Mammosite treatment. “Currently we are allowing the treatment for women who have early breast cancers, that have small breast cancers and also women who have large breasts. We are still being really selective and really picking patients that we think are the best candidates for this. I know that as time goes on and we get more experience our criteria will expand.”

Mammosite was approved by the FDA in 2002. Since then it has been used on more than 40,000 patients nationwide. Many breast cancer patients who have been treated with localized radiation say the result is also cosmetically appealing.